HealthKey ads, reviews and marketing in August 2026
They position HealthKey as AI software for clinical trial patient prescreening inside EHR data. Their current advertising relies on repeated quantified case studies, a clear mechanism, and a short call booking. You can compete by making your proof easier to verify and by showing more of the operational workflow than their repeated text ads do.
- Researched
- 29 August 2026
- Site
- gethealthkey.com
- Ads read in
- US
- Sources
- 1 of 9 answered
- 12
- ads found
- 0
- reviews found
- 1
- sources read
- Not rated
- review rating
Best opening
Positioning
12 of their 12 ads center on finding eligible patients, so claim a narrower advantage that matters after matching, such as enrollment likelihood, coordinator review time, or trial completion.
Moves worth carrying forward
Creative
12 of their 12 ads use the same text-led treatment, so make your first test a product-led visual that shows the path from protocol criteria to reviewed patient records.
Campaign
12 of their 12 ads speak to clinical research teams, so build at least 2 audience-specific variants with different pain points and proof.
What HealthKey is running
HealthKey ads, read · 12 of 12 read one by one · 2026-08-29T12:40:40.464Z
All 12 ads use the same text-led, results-focused message for clinical research sites. They lead with specific patient and time counts, explain EHR prescreening as the mechanism, and end with a 15-minute call. The repeated creative gives you a clear opening to differentiate through a sharper workflow explanation, proof structure, or audience segment.
- 12
- active ads
- 0%
- video
- 0
- median days running
- 0
- longest run, days
- 12
- creative variants
- not read
- EU reachno detail pass yet
Format
Running for
12 of 12 ads · fetched 2026-08-29 · first run, nothing to compare against
HealthKey (YC W25)
Josh Sabol %FIRSTNAME%, we just identified 6 rare cancer patients for a trial that’s been stuck at zero rands for 2 years… in our 1st week.nbsp;How?We use AI to prescreen entire EHRs to surface patients who actually qualify for your clinical trials. Instead of CRCs spending hours manually scrubbing charts, we scan 80,000 patients and find the exact 42 who are eligible, ranked by how likely they are to enroll.That is just one example, we also worked with US Urology Partners to find 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial and had Tekton Research go from a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.Care to see? Book a 15-minute no-obligations call to learn how AI actually helps research sites.
US
HealthKey (YC W25)
Josh Sabol %FIRSTNAME%, we just identified 6 rare cancer patients for a trial that’s been stuck at zero rands for 2 years… in our 1st week.nbsp;How?We use AI to prescreen entire EHRs to surface patients who actually qualify for your clinical trials. Instead of CRCs spending hours manually scrubbing charts, we scan 80,000 patients and find the exact 42 who are eligible, ranked by how likely they are to enroll.That is just one example, we also worked with US Urology Partners to find 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial and had Tekton Research go from a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.Care to see? Book a 15-minute no-obligations call to learn how AI actually helps research sites.
US
HealthKey (YC W25)
Josh Sabol %FIRSTNAME%, we just identified 6 rare cancer patients for a trial that’s been stuck at zero rands for 2 years… in our 1st week.nbsp;How?We use AI to prescreen entire EHRs to surface patients who actually qualify for your clinical trials. Instead of CRCs spending hours manually scrubbing charts, we scan 80,000 patients and find the exact 42 who are eligible, ranked by how likely they are to enroll.That is just one example, we also worked with US Urology Partners to find 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial and had Tekton Research go from a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.Care to see? Book a 15-minute no-obligations call to learn how AI actually helps research sites.
US
HealthKey (YC W25)
Josh Sabol %FIRSTNAME%, we just identified 6 rare cancer patients for a trial that’s been stuck at zero rands for 2 years… in our 1st week.nbsp;How?We use AI to prescreen entire EHRs to surface patients who actually qualify for your clinical trials. Instead of CRCs spending hours manually scrubbing charts, we scan 80,000 patients and find the exact 42 who are eligible, ranked by how likely they are to enroll.That is just one example, we also worked with US Urology Partners to find 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial and had Tekton Research go from a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.Care to see? Book a 15-minute no-obligations call to learn how AI actually helps research sites.
US
HealthKey (YC W25)
Josh Sabol %FIRSTNAME%, we just identified 6 rare cancer patients for a trial that’s been stuck at zero rands for 2 years… in our 1st week.nbsp;How?We use AI to prescreen entire EHRs to surface patients who actually qualify for your clinical trials. Instead of CRCs spending hours manually scrubbing charts, we scan 80,000 patients and find the exact 42 who are eligible, ranked by how likely they are to enroll.That is just one example, we also worked with US Urology Partners to find 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial and had Tekton Research go from a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.Care to see? Book a 15-minute no-obligations call to learn how AI actually helps research sites.
US
HealthKey (YC W25)
Josh Sabol %FIRSTNAME%, we just identified 6 rare cancer patients for a trial that’s been stuck at zero rands for 2 years… in our 1st week.nbsp;How?We use AI to prescreen entire EHRs to surface patients who actually qualify for your clinical trials. Instead of CRCs spending hours manually scrubbing charts, we scan 80,000 patients and find the exact 42 who are eligible, ranked by how likely they are to enroll.That is just one example, we also worked with US Urology Partners to find 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial and had Tekton Research go from a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.Care to see? Book a 15-minute no-obligations call to learn how AI actually helps research sites.
US
Research receiptSources, retention and creditsHide details
What this run read
12 credits spent
Ad copy and review text are quoted from the linked public pages.
This is a public page on kamplyapp.com. It stays up until its owner takes it down.
